BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35044423)

  • 1. Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.
    Der Sarkissian S; Hessam S; Kirby JS; Lowes MA; Mintoff D; Naik HB; Ring HC; Chandran NS; Frew JW
    JAMA Dermatol; 2022 Mar; 158(3):300-313. PubMed ID: 35044423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.
    Frew JW; Lowes MA; Goldfarb N; Butt M; Piguet V; O'Brien E; Ingram J; Jemec GBE; Tan J; Zouboulis C; Alavi A; Kirby JS
    JAMA Dermatol; 2021 Apr; 157(4):449-455. PubMed ID: 33688910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic Gaps and Requirements for Participation: A Systematic Review of Clinical Trial Designs in Hidradenitis Suppurativa.
    James JF; Madray VM; Salame N; Hasan SB; White MS; Barron JR; Kirby J; Ingram JR; Orenstein LAV
    Dermatology; 2023; 239(1):45-51. PubMed ID: 36108592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.
    Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC
    JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity.
    Grand D; Frew JW; Navrazhina K; Krueger JG
    Br J Dermatol; 2021 Apr; 184(4):688-696. PubMed ID: 32602132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the management of hidradenitis suppurativa in the Middle East region: a systematic review.
    Karvar M; Panayi AC; Alavi A; Baziar Z; Orgill DP
    Int J Dermatol; 2021 Nov; 60(11):e440-e448. PubMed ID: 33615455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A narrative review of the definition of 'flare' in hidradenitis suppurativa.
    Kirby JS; Moore B; Leiphart P; Shumaker K; Mammis-Gierbolini A; Benhadou F; Del Marmol V
    Br J Dermatol; 2020 Jan; 182(1):24-28. PubMed ID: 31025310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.
    Glatt S; Jemec GBE; Forman S; Sayed C; Schmieder G; Weisman J; Rolleri R; Seegobin S; Baeten D; Ionescu L; Zouboulis CC; Shaw S
    JAMA Dermatol; 2021 Nov; 157(11):1279-1288. PubMed ID: 34406364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS).
    Wortsman X; Castro A; Figueroa A
    J Am Acad Dermatol; 2016 Oct; 75(4):760-767. PubMed ID: 27498279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Case-Finding Algorithm for Hidradenitis Suppurativa Using Administrative Coding from a Clinical Database.
    Strunk A; Midura M; Papagermanos V; Alloo A; Garg A
    Dermatology; 2017; 233(1):53-57. PubMed ID: 28448975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
    Kucinskiene V; Jariene V; Valiukeviciene S
    Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment tools and phenotype classification for hidradenitis suppurativa.
    Koerts NDK; Bouwman K; Prens LM; Horváth B
    Clin Dermatol; 2023; 41(5):601-610. PubMed ID: 37652190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of International Management Guidelines for Hidradenitis Suppurativa.
    Hendricks AJ; Hsiao JL; Lowes MA; Shi VY
    Dermatology; 2021; 237(1):81-96. PubMed ID: 31645040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.